| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220909A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220663A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 07/10/2002 | EP1220656A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 07/10/2002 | EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1357387A Foot refreshing powder |
| 07/10/2002 | CN1357378A Trauma treating medicine |
| 07/10/2002 | CN1357371A Name, recipe and prepn proces sof body-scenting and face-beautifying capsule |
| 07/10/2002 | CN1357369A Externally applied ointment for treating burns, wound and frost bite and its prepn |
| 07/10/2002 | CN1357366A Tinea-eliminating detoxicating pellet |
| 07/10/2002 | CN1357365A Medicine for treating white hairs |
| 07/10/2002 | CN1357330A Externally-applied medicine for treating dermatosis |
| 07/10/2002 | CN1357321A Inflammation and red spot reducing method |
| 07/10/2002 | CN1087167C Face mask for eliminating maculae and wrinkle and whitening skin and its preparing process |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417226 Contain alph-hydroxytetronic acid or a derivative, and, in some cases, hydroquinone, an alpha -hydroxy acid such as glycolic acid, and a fatty acid ester of ascorbic acid such as ascorbyl palmitate. |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416773 Cosmetic or dermatological light protection agent preparations |
| 07/09/2002 | US6416767 Use of peroxidized lipids as agents intended to prevent and/or to treat the irritant effects of an active principle |
| 07/09/2002 | CA2367232A1 Topical compositions for active wound healing with decreased scarring |
| 07/09/2002 | CA2061566C Treatment of disease employing hyaluronic acid and nsaids |
| 07/09/2002 | CA2026763C Cosmetic or pharmaceutical composition for topical use, comprising at least one retinoid derivation and at least one pyrimidine derivative, use of same for medical purpose, and method of using same |
| 07/04/2002 | WO2002052019A2 22437, a human sulfatase and uses therefor |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051855A2 Motilide compounds |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051828A2 Novel c-glycoside derivatives and use thereof |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051805A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051436A2 Stable enzymatic wound debrider |
| 07/04/2002 | WO2002051427A1 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051374A1 Hair growth inhibitors and compositions containing the same |
| 07/04/2002 | WO2002051352A2 New uses of insulin and pancreatin |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001091682A8 Composition and applicator for topical substance delivery |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/04/2002 | WO2001034099A9 Soy depigmenting and skin care compositions |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | US20020087015 High intestinal calcium transport activity and relatively high bone calcium mobilization activity; treating osteoporosis, cancer, psoriasis |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086906 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics |
| 07/04/2002 | US20020086905 Gel for treatment of skin diseases and for disinfection of the skin |
| 07/04/2002 | US20020086882 Regulates immune and inflammatory responses by binding to alpha 4 integrin, also know as Very Late Antigen; antiinflammatory agent |
| 07/04/2002 | US20020086862 1,2,4-triazole-3-thione compounds; treatment of disorders such as ischaemia, psoriasis |
| 07/04/2002 | US20020086854 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086049 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 07/04/2002 | US20020086042 Cosmetic particulate gel carriers for topically applied active agents |
| 07/04/2002 | US20020086039 As preservative |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020085615 Differential scanning calorimeter |
| 07/04/2002 | DE10065047A1 Gelcèmes in Form von O/W-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumaryloyldimethyltaurat/vinylpyrrolidoncopolymeren Gelcèmes in the form of O / W emulsions with a content of one or more Ammoniumaryloyldimethyltaurat / vinylpyrrolidoncopolymeren |
| 07/04/2002 | DE10063435A1 Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Chinazolinderviate, medicaments containing these compounds, their use and process for their preparation |
| 07/04/2002 | DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products |
| 07/04/2002 | CA2436739A1 Combination agent |